Emerging therapeutic options for myelofibrosis: a Canadian perspective.
about
Emerging treatment options for myelofibrosis: focus on pacritinibColorectal Liver Metastasis, Primary Gallbladder Carcinoma and Myelofibrosis Present Simultaneously in a Liver Resection Specimen.A case of Philadelphia chromosome positive myeloproliferative neoplasm in a pregnant woman with unusual primary myelofibrosis features
P2860
Emerging therapeutic options for myelofibrosis: a Canadian perspective.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Emerging therapeutic options for myelofibrosis: a Canadian perspective.
@en
type
label
Emerging therapeutic options for myelofibrosis: a Canadian perspective.
@en
prefLabel
Emerging therapeutic options for myelofibrosis: a Canadian perspective.
@en
P2093
P2860
P1476
Emerging therapeutic options for myelofibrosis: a Canadian perspective.
@en
P2093
A Robert Turner
Lambert Busque
Lynda Foltz
Shireen Sirhan
Vikas Gupta
P2860
P304
P577
2012-09-23T00:00:00Z